
INOVIO, a biotech company specializing in DNA medicines for HPV-related diseases and cancer, will announce its Q1 2026 financial results after market close on May 13, 2026. The company will hold a live conference call and webcast at 4:30 p.m. ET to discuss the results and provide a business update, including a live Q&A session with analysts. The webcast will be accessible online and archived for 90 days. This event offers investors insight into INOVIO's progress and financial health.